Who
Ruben A. Garcia
General Counsel
Company insider
Files Form 4 as: General Counsel, FibroBiologics.
In numbers
- Trades disclosed
- 8
- Buys
- 2
- Sells
- 0
- Bought
- $74K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Mar 2024
- Last trade
- 4 May 2026
- Last filed
- 4 May 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 May 2026filed 4 May 2026 | FBLG FibroBiologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —61,607 at $0.00 | filing |
| 4 May 2026filed 4 May 2026 | FBLG FibroBiologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —61,607 at $0.00 | filing |
| 27 Feb 2026filed 2 Mar 2026 | FBLG FibroBiologicsBiotechnology | SEC FORM 4 Bought | $13K40,000 at $0.3264 | filing |
| 27 Feb 2026filed 2 Mar 2026 | FBLG FibroBiologicsBiotechnology | SEC FORM 4 Bought | $13K40,000 at $0.33 | filing |
| 11 Dec 2025filed 12 Dec 2025 | FBLG FibroBiologicsBiotechnology | SEC FORM 4 Bought | $48K140,000 at $0.34 | filing |
| 26 Mar 2025filed 28 Mar 2025 | FBLG FibroBiologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —189,000 at $0.00 | filing |
| 27 Dec 2024filed 30 Dec 2024 | FBLG FibroBiologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —176,200 at $0.00 | filing |
| 1 Mar 2024filed 8 Mar 2024 | FBLG FibroBiologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
News
FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting – Ortho Spine NewsFBLG · orthospinenews.com · 19 Oct 2026
0 headlines in the last 90 days name Ruben A. Garcia; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.